The International Journal of Peptide Research and Therapeutics publishes the latest developments in peptide therapeutics and high quality research covering all aspects of peptide science. The journal brings together in a single source the most exciting peer-reviewed work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives.

Coverage includes new advances in peptide drug delivery systems; application of peptide therapeutics to specific diseases; advances in synthetic methods; development of new procedures for construction of peptide libraries and methodology for screening of such mixtures; the use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions; applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography; mass spectrometry.

IJPRT requests that all authors comply to Springer’s ethical policies. These ethical statements should be clearly indicated on all articles for all 3 ethics statements and for all authors mentioned by name. These statements should be placed at the end of each article just before the Reference section.

Find our ethics statements here:

Conflict of Interest and Ethical Standards: 
http://www.springer.com/authors?SGWID=0-111-6-791531-0

Informed Consent:
http://www.springer.com/authors?SGWID=0-111-6-608209-0  

Statement of Human and Animal Rights:
http://www.springer.com/authors?SGWID=0-111-6-608309-0

Please note that manuscripts that solely describe in silico work that does not include subsequent validating laboratory data will not be considered and will be rejected at the submission stage. 

 

  • Publishes the latest developments in peptide therapeutics and high quality research covering all aspects of peptide science
  • Aids in the development of unifying concepts from diverse perspectives
  • Covers advances in peptide drug delivery systems; application of peptide therapeutics to specific diseases; advances in synthetic methods; development of new procedures for construction of peptide libraries, and more
  • Gold OA options and funding available!
  • Please note that manuscripts that solely describe in silico work that does not include subsequent validating laboratory data will not be considered and will be rejected at the submission stage. 
  • 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

Editors-in-Chief
  • Fernando Albericio,
  • John D. Wade
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

2.191 (2021)
Impact factor
2.028 (2021)
Five year impact factor
17 days
Submission to first decision (Median)
180,989 (2021)
Downloads

Latest articles

This journal has 67 open access articles

Journal updates

View all updates

About this journal

Electronic ISSN
1573-3904
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. Biological Abstracts
  6. CAB Abstracts
  7. CLOCKSS
  8. CNKI
  9. CNPIEC
  10. Chemical Abstracts Service (CAS)
  11. Dimensions
  12. EBSCO Academic Search
  13. EBSCO Biomedical Reference Collection
  14. EBSCO Discovery Service
  15. EMBASE
  16. EMBiology
  17. Google Scholar
  18. Japanese Science and Technology Agency (JST)
  19. Journal Citation Reports/Science Edition
  20. Meta
  21. Naver
  22. OCLC WorldCat Discovery Service
  23. Portico
  24. ProQuest-ExLibris Primo
  25. ProQuest-ExLibris Summon
  26. Reaxys
  27. SCImago
  28. SCOPUS
  29. Science Citation Index Expanded (SCIE)
  30. TD Net Discovery Service
  31. UGC-CARE List (India)
  32. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature B.V.